The Hub for Disease-Specific Clinical Information
Advertisement
Advertisement

Jessica S. Donington, MD, on Treating Early-Stage Thoracic Cancers

Posted: Tuesday, March 19, 2019

Jessica S. Donington, MD, of the University of Chicago, discusses the role of adjuvant or neoadjuvant therapy for early-stage thoracic tumors and the currently available or investigational classes of agents that are most likely to be useful in these settings.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.